Loading...
XLONGNS
Market cap1.25bUSD
Dec 24, Last price  
1,524.00GBP
1D
0.26%
1Q
-19.96%
Jan 2017
-15.14%
Name

Genus PLC

Chart & Performance

D1W1MN
XLON:GNS chart
P/E
12,672.38
P/S
149.69
EPS
0.12
Div Yield, %
0.02%
Shrs. gr., 5y
0.27%
Rev. gr., 5y
6.48%
Revenues
669m
-3.03%
113,904,000201,200,000233,800,000247,100,000280,400,000285,300,000309,900,000341,800,000345,300,000372,200,000398,500,000388,300,000459,100,000470,300,000488,500,000551,400,000574,300,000593,400,000689,700,000668,800,000
Net income
8m
-76.28%
5,569,0007,800,00014,600,00017,700,00017,900,00027,500,00029,200,00039,600,00027,000,00028,900,00039,900,00049,300,00032,800,00042,700,0007,800,00035,300,00047,300,00040,900,00033,300,0007,900,000
CFO
30m
-40.87%
4,728,000-15,700,00014,200,00013,000,00013,700,00026,200,00027,900,00032,400,00024,000,00032,299,99934,800,00030,000,00034,600,00043,200,00033,400,00060,100,00067,500,00034,300,00050,400,00029,800,000
Dividend
Nov 07, 202421.7 GBP/sh
Earnings
Feb 20, 2025

Profile

Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand. The company also sells bull semen and embryos to breed calves with various characteristics for milk and beef production under the ABS, Genus, and Bovec brands. In addition, it offers technical services to farmers. The company was incorporated in 1994 and is based in Basingstoke, the United Kingdom.
URL
https://www.genusplc.com
IPO date
Jul 06, 2000
Employees
3,500
Domiciled in
GB
Incorporated in
GB

Valuation

Title
GBP in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑062016‑062015‑06
Income
Revenues
668,800
-3.03%
689,700
16.23%
593,400
3.33%
Cost of revenue
636,500
636,800
529,700
Unusual Expense (Income)
NOPBT
32,300
52,900
63,700
NOPBT Margin
4.83%
7.67%
10.73%
Operating Taxes
3,100
16,600
11,700
Tax Rate
9.60%
31.38%
18.37%
NOPAT
29,200
36,300
52,000
Net income
7,900
-76.28%
33,300
-18.58%
40,900
-13.53%
Dividends
(21,000)
(21,000)
(20,900)
Dividend yield
1.92%
1.47%
1.27%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
18,900
14,200
17,200
Long-term debt
330,400
249,800
206,600
Deferred revenue
23,400
200
Other long-term liabilities
17,700
600
(60,500)
Net debt
245,200
152,300
133,600
Cash flow
Cash from operating activities
29,800
50,400
34,300
CAPEX
(14,800)
(35,200)
(42,100)
Cash from investing activities
(19,300)
(30,900)
(67,200)
Cash from financing activities
(2,800)
(18,200)
21,900
FCF
(20,600)
38,200
(14,900)
Balance
Cash
42,500
36,300
38,800
Long term investments
61,600
75,400
51,400
Excess cash
70,660
77,215
60,530
Stockholders' equity
370,400
393,700
393,100
Invested Capital
782,140
730,985
758,070
ROIC
3.86%
4.88%
7.62%
ROCE
3.60%
6.16%
7.25%
EV
Common stock shares outstanding
66,174
65,998
65,714
Price
16.50
-23.82%
21.66
-13.64%
25.08
-49.44%
Market cap
1,091,871
-23.62%
1,429,517
-13.26%
1,648,107
-49.40%
EV
1,338,271
1,579,617
1,775,307
EBITDA
79,200
96,500
98,500
EV/EBITDA
16.90
16.37
18.02
Interest
21,700
14,300
6,200
Interest/NOPBT
67.18%
27.03%
9.73%